AGM results: all 6 resolutions passed, Re.1.20 dividend declared

Board & Shareholder Meetings View source PDF Explain this filing

BLUEJET · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹587.05

prior close

₹589.95

announcement price

After-mkt

timing

Nifty Smallcap 250market+0.8%-1.3% vs market

Pharmaceuticals peers, median of 173sector+0.5%-1.0% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Smallcap 250 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.7

15m

-0.5

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4+0.8-1.3+0.5-1.0

Next day

-2.3-0.6-1.7-0.5-1.8

-2.6-0.6-2.1-0.1-2.5

-4.8-2.2-2.6-0.9-3.9

-5.4-2.8-2.6-0.4-4.9

-8.9-2.5-6.3-2.0-6.9

-9.3-3.3-6.0-3.1-6.2

15d

-11.7-3.5-8.3-4.8-6.9

-19.1-10.3-8.8-9.7-9.3

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Blue Jet Healthcare held its 58th AGM on September 21, 2026 via video conferencing. All 6 resolutions were passed. Key items: adoption of FY26 audited financial statements (99.9999% in favour), declaration of dividend of Re.1.20 per share for FY26 (100% in favour), re-appointment of statutory auditors KKC and Associates LLP, and re-appointment of directors Mr. Naresh Shah, Mr. Akshay Arora (Executive Chairman) and Mr. Shiven Arora (Managing Director). About 78.56% of total shares participated in voting. Institutional investors showed some dissent (around 12%) on director re-appointments, but all resolutions passed comfortably.

Likely market impact

Re.1.20 per share dividend confirmed for eligible shareholders. Director re-appointments secured. Mild dissent from institutions on board re-appointments.